Unlike traditional methods, these drugs target the body's biological hunger signals directly
In a parallel study of those on weight loss medicines, researchers compared about 171,000 who were on GLP-1 medications with about 197,000 who were on other weight loss drugs, and found that liraglutide (Saxenda) more than doubled the incidence of delayed gastric emptying, and that semaglutide (Wegovy) increased this side effect by more than a third (39%) compared to non-GLP-1 drugs
Older patients are more likely to experience blurred vision when starting with the medication
Is it safe to take phentermine and GLP-1 (Glucagon-like peptide-1) receptor agonists together?
(PubMed) Shulpekova Y, Nechaev V, Kardasheva S, et al
Prader-Willi Syndrome: Individuals navigating the complexities of Prader-Willi syndrome, an uncommon genetic disorder marked by muscle weakness and insatiable appetite leading to obesity, discover respite in HGH treatment [10]